|
||
---|---|---|
UniProt ID |
Q6UVK1 |
|
Entry Name |
CSPG4_HUMAN |
|
Protein Name |
Chondroitin sulfate proteoglycan 4 |
|
Primary Gene Name |
CSPG4 |
|
Organism |
Homo sapiens (Human) |
|
Molecular Function |
Developmental protein |
|
Membrane Location |
Cell membrane |
|
---|
Substrate Name | Chondroitin sulfate proteoglycan 4 (NG2) | |
Cell Type | ||
Substrate Description | proteoglycan invovled in cell proliferation and migration, neurite outgrowth inhibition | |
Substrate Function Category | cell surface structure | |
Substrate Function Subtype | cell adhesion molecule | |
Sheddase | metalloproteinase | |
Shedding-related Disease | proteoglycan | |
Short Summary of Papers | shedding of NG2 represents a mechanism for decreasing responsiveness to PDGF, involved in the control of cell proliferation | |
Cleavage Information | NONE | |
PMID | 15866049 |
|
---|
|
||
---|---|---|
|
Start | End |
|
30 | 2224 |
|
2225 | 2245 |
|
||||||||
---|---|---|---|---|---|---|---|---|
Database | CutSeq | Mapped Position | Protease | Type | Evidence | PMID | ||
MEROPS | SLSQ*QQLR | 1963 | matrix metallopeptidase-2 | not physiologically relevant | Mass spectroscopy | 18500335    | ||
MEROPS | SDRE*EPEA | 1973 | glutamyl peptidase I | not physiologically relevant | Mass spectroscopy | 18500335    | ||
PAPER | PRAR*TEPG | 2101 | UNKNOWN | Mass spectrometry | 33796845    | |||
ASCENT | ARPY*SVAL | 2171 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    |
|
|||
---|---|---|---|
Secretome Database | Cell Type or Body Fluid | PubMed Reference | |
Sys-BodyFluid | Amniotic fluid | 17495049 | |
Sys-BodyFluid | Saliva | 18361515 | |
Sys-BodyFluid | Cerebrospinal fluid | 18052119 | |
Sys-BodyFluid | Urine | 16335936 | |
Sys-BodyFluid | Urine | 16948836 | |
HCSD | cancer (gastric cancer) | 23161554 | |
HCSD | cancer(23 cancer cell lines) | 20124221 | |
HCSD | cancer(colorectal cancer | 22408128 | |
HCSD | cancer(colorectal cancer | 24418523 | |
HCSD | cancer(ovarian cancer) | 22623176 | |
HCSD | cancer(oral cancer ) | 21714544 | |
HCSD | cancer(Glioblastoma) | 23483059 |